Benefit-risk methodology project Work package 2 report : Applicability of current tools and processes for regulatory benefit-risk assessment

@inproceedings{2011BenefitriskMP,
  title={Benefit-risk methodology project Work package 2 report : Applicability of current tools and processes for regulatory benefit-risk assessment},
  author={},
  year={2011}
}
  • Published 2011

From This Paper

Figures, tables, and topics from this paper.

Citations

Publications citing this paper.

References

Publications referenced by this paper.
Showing 1-10 of 78 references

A United States Regulator's Perspective on Risk-Benefit Considerations. Risk-Benefit Considerations in Drug Regulatory Decision-Making

  • J. Jenkins
  • Shady Grove Conference
  • 2010

A Multiattribute Model for Evaluating the BenefitRisk Profiles of Treatment Alternatives

  • Rebecca A Felli JCN, Patrizia A. Cavazzoni
  • Medical Decision Making
  • 2009

Benefit-Risk Appraisal of Medicines: A Systematic Approach to Decision-Making

  • F Mussen, S Salek, S. Walker
  • 2009

Commentaries on 'A quantitative approach to benefit-risk assessment of medicines

  • E Abadie, G Alvan, A Breckenridge, B Flamion, D. Jefferys
  • Pharmacoepidemiology and Drug Safety. 2007;16:S42…
  • 2009

Decision Analysis for Management Judgment

  • P Goodwin, G. Wright
  • 2009

Similar Papers

Loading similar papers…